BIO insider buying and SEC filings, explained
Bio-Rad Laboratories, Inc. · CIK 12208
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Company profile
- Exchanges
- NYSE, NYSE
- Industry (SIC)
- Laboratory Analytical Instruments
- State of incorporation
- DE
- Fiscal year end
- Dec 31
- Former names
- BIO RAD LABORATORIES INC
Insider activity in the last 12 months
Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$350K
Planned sales (10b5-1)
$0
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| May 11, 2026 | Sale | Eva Anette Engelhardt (President / COO) sold 550 shares at $246.54 ($136K). Holdings down 61% to 346 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed May 13, 2026 |
| Nov 6, 2025 | Sale | James Barry (President / COO) sold 700 shares at about $306.18 ($214K). Holdings down 58% to 510 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Nov 10, 2025 |
21 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow BIO in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.